Radioiodine imaging (WBS) and serum thyroglobulin(TG) in management of thyroid cancer (DTC): Randomised study with recombinant human TSH (rhTSH) and without thyroid hormone

被引：0
|
作者：
Bertolazzi, L
Zoccola, R
Giusti, M
Villa, G
Scattina, M
机构：
[1] Univ Genoa, Dept Nucl Med, Genoa, Italy
[2] Univ Genoa, DISEM, Genoa, Italy
[3] Univ Genoa, DIMI, Genoa, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 2001年 / 28卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
PS520
引用
收藏
页码：1209 / 1209
页数：1
相关论文
共 50 条
  • [41] Intravenous radioiodine and recombinant human TSH in a patient with extensive thyroid cancer. Report of one case
    Spuler, Jane
    Paillahueque, Gabriela
    Gonzalez, Patricio
    Campos, David
    [J]. REVISTA MEDICA DE CHILE, 2018, 146 (10) : 1220 - 1223
  • [42] Repeatitive use of recombinant human TSH in radioiodine therapy of follicular thyroid cancer with multiple skeletal metastasis
    Pradhan, P.
    Jain, S.
    Gambhir, S.
    Arya, A.
    Verma, S.
    Murthy, S.
    Yadav, N.
    Shukla, A. K.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S504 - S504
  • [43] 18F Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (PET) after RhTSH stimulation in Differentiated Thyroid Cancer (DTC) and increased Thyroglobulin serum levels (Tg) with negative 131I Whole Body scan (WBS)
    Panareo, S.
    Cittanti, C.
    Santi, I.
    Rossi, R.
    Uberti, E. Degli
    Feggi, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S466 - S466
  • [44] Postoperative basal serum thyroglobuline (TG) prior to radioiodine therapy as a predictive factor of recurrence in patients with differentiated thyroid cancer (DTC)
    Nunez Munoz, R.
    Carreres Ortega, Y.
    Astudillo Sarmiento, M. A.
    Valverde Jorge, R.
    Nevares Herrero, M.
    Genolla Subirats, J.
    Santamaria Sandi, J.
    Badiola Molinuevo, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S436 - S436
  • [45] Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer in children, adolescents and young adults
    Schumm, Max A.
    Pyo, Howard Q.
    Kim, Jiyoon
    Tseng, Chi-Hong
    Yeh, Michael W.
    Leung, Angela M.
    Chiu, Harvey K.
    [J]. CLINICAL ENDOCRINOLOGY, 2021, 95 (02) : 344 - 353
  • [46] Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective
    Sohn, Seo Young
    Jang, Hye Won
    Cho, Yoon Young
    Kim, Sun Wook
    Chung, Jae Hoon
    [J]. ENDOCRINOLOGY AND METABOLISM, 2015, 30 (04) : 531 - 542
  • [47] Radioiodine therapy after hormone withdrawal and recombinant human thyrotropin (rhTSH) after redifferentiation with isotretinoin in patients with dedifferentiated thyroid carcinoma.
    Sandrock, DH
    Kettner, BI
    Munz, DL
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 309P - 309P
  • [48] Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone -: Authors' response
    Rudavsky, AZ
    Freeman, LM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12): : 4277 - 4278
  • [49] Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
    Pitoia, Fabian
    Marlowe, Robert J.
    Abelleira, Erika
    Faure, Eduardo N.
    Bueno, Fernanda
    Schwarzstein, Diego
    Julio Lutfi, Ruben
    Niepomniszcze, Hugo
    [J]. JOURNAL OF THYROID RESEARCH, 2012, 2012
  • [50] Management of differentiated thyroid carcinoma by serum thyroglobulin and 131I scintigraphy after recombinant human TSH and 99mTc-Sestamibi
    Villa, G
    Giusti, M
    Zoccola, R
    Guazzini, B
    Molinari, E
    Castagnola, F
    Bertolazzi, L
    Minuto, F
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1206 - 1206
12345